S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in

Marijuana Company of America Stock Forecast, Price & News

0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume138.25 million shs
Average Volume236.69 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Marijuana Company of America, Inc., through its subsidiaries, engages in the product research and development of hemp-derived consumer products under the hempSMART brand name in the United States and internationally. The company's hempSMART products include hempSMART Brain, a patented formula that combines hemp-derived cannabidiol (CBD) for brain; hempSMART Pain capsules for relief of minor discomfort with physical activity; hempSMART Pain Cream for muscle relief; hempSMART Drops, hemp CBD oil tincture drops; hempSMART Pet Drops for cats and dogs; and hempSMART Face, a facial moisturizer. It also participates in an affiliate marketing program to promote and sell its legal hemp-derived consumer products containing CBD; and provides financial accounting and bookkeeping, and property management consulting services for entities that are engaged in the operation of cannabis for medicinal and recreational use in legalized states. The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was incorporated in 1985 and is headquartered in Escondido, California.


See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Current SymbolOTCMKTS:MCOA
Previous SymbolNASDAQ:MCOA
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.52 out of 5 stars

Medical Sector

1481st out of 1,969 stocks

Drug Manufacturers - Specialty & Generic Industry

42nd out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MCOA News and Ratings via Email

Sign-up to receive the latest news and ratings for MCOA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Marijuana Company of America (OTCMKTS:MCOA) Frequently Asked Questions

What stocks does MarketBeat like better than Marijuana Company of America?

Wall Street analysts have given Marijuana Company of America a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Marijuana Company of America wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Marijuana Company of America?

Marijuana Company of America saw a drop in short interest during the month of February. As of February 12th, there was short interest totaling 8,400 shares, a drop of 81.7% from the January 28th total of 45,800 shares. Based on an average daily volume of 510,950,800 shares, the short-interest ratio is currently 0.0 days.
View Marijuana Company of America's Short Interest

How has Marijuana Company of America's stock been impacted by Coronavirus (COVID-19)?

Marijuana Company of America's stock was trading at $0.0250 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MCOA stock has decreased by 64.8% and is now trading at $0.0088.
View which stocks have been most impacted by COVID-19

Who are Marijuana Company of America's key executives?

Marijuana Company of America's management team includes the following people:
  • Mr. Jesus M. Quintero CPA, CPA, Chairman, Pres, CEO, CFO, Principal Exec. Officer, Principal Accounting Officer & Treasurer (Age 59, Pay $98k)
  • Mr. Robert E. Brown, Exec. VP (Age 93)
  • Ms. Gloria Albarran-Lynch, Chief Marketing Officer & COO
  • Ms. Brenda A. Andrews, Corp. Communications & Marketing Director
  • Mr. Alexander Shirokov, Pres of Sintek Inc

Who are some of Marijuana Company of America's key competitors?

What other stocks do shareholders of Marijuana Company of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marijuana Company of America investors own include Freeport-McMoRan (FCX), (CGC), Generation Next Franchise Brands (VEND), Aurora Cannabis (ACB), Medical Marijuana (MJNA), Cannabis Science (CBIS), Conatus Pharmaceuticals (CNAT), KushCo (KSHB), Aurora Cannabis (ACBFF) and First Solar (FSLR).

What is Marijuana Company of America's stock symbol?

Marijuana Company of America trades on the OTCMKTS under the ticker symbol "MCOA."

How do I buy shares of Marijuana Company of America?

Shares of MCOA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Marijuana Company of America's stock price today?

One share of MCOA stock can currently be purchased for approximately $0.01.

How many employees does Marijuana Company of America have?

Marijuana Company of America employs 4 workers across the globe.

What is Marijuana Company of America's official website?

The official website for Marijuana Company of America is www.marijuanacompanyofamerica.com.

Where are Marijuana Company of America's headquarters?

Marijuana Company of America is headquartered at 1340 W Valley Pkwy Ste 205, ESCONDIDO, CA 92029-2136, United States.

How can I contact Marijuana Company of America?

Marijuana Company of America's mailing address is 1340 W Valley Pkwy Ste 205, ESCONDIDO, CA 92029-2136, United States. The company can be reached via phone at +1-303-9744770.

This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.